<DOC>
	<DOCNO>NCT01510574</DOCNO>
	<brief_summary>Postpartum hemorrhage ( PPH ) major cause maternal death develop world . An important strategy prevention death use uterotonic drug PPH prophylaxis . Misoprostol recognize option prevent PPH economical , heat stable , long shelf-life , take orally . The investigator envisage use self administer misoprostol home birth among mother would associate peri-partum fall hemoglobin value 20 % ( outcome fall 2g/dl also test pilot ) . The objective main study ass effectiveness safety antenatal administration misoprostol tablet ( 600mcg ) self administration immediately follow home delivery prevention postpartum haemorrhage . The objective pilot study test integrity study protocol , test randomization procedure , assess acceptability intervention , test logistics follow-up , test data collection form , validate quality life questionnaire population determine recruitment rate help study planning .</brief_summary>
	<brief_title>A Study Self-administered Misoprostol Prevent Bleeding After Childbirth Community ( MamaMiso )</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>pregnant woman live recruitment village Mbale district &gt; 34 week gestation Any woman know allergy misoprostol prostaglandin exclude woman 18 year old ( unless emancipate minor )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>postpartum hemorrhage , PPH , misoprostol</keyword>
</DOC>